NIDA director Volkow gets candid on addiction in Bhattacharya’s podcast

Science advocates organize march in DC to demand impeachment of RFK Jr.

Scientists, health care professionals, and supporters will take to the streets on Nov. 5, calling for Congress to remove Robert F. Kennedy Jr. from his position as Secretary of Health and Human Services.

Federal official claims that temporary order blocking RIFs doesn’t apply to HHS

A court filing by Thomas Nagy Jr., deputy assistant secretary for Human Resources and chief human capital officer at HHS, claims that his department can proceed with the 982 RIFs it issued two weeks ago, despite a judge’s temporary order freezing the notices issued by two dozen federal agencies since the government shutdown that began on Oct 1.

October 24, 2025

Vol.51 No.39

By Sara Willa Ernst

Clinical Regulatory News Trials & Tribulations

Under the lens: Taking a close look at the NIH and FDA declarations on animal-based research

In April 2025, announcements from the two most influential biomedical agencies in the US, the FDA and the NIH, declared that both will seek to reduce and minimize animal-based testing and experimentation. These declarations sparked joy in some circles, and deep concern in others that was reflected in a 28% fall in the share price of Charles River Labs (NYSE: NYSE:CRL).

October 17, 2025

Vol.51 No.38

By Edison T. Liu

News Analysis Regulatory News

How animal testing became a MAHA political wedge issue
While cancer scientists say NIH, FDA moves are premature, animal rights advocates say changes aren’t drastic enough

Bowing to the growing animal rights movement, FDA and NIH have made policy changes to discourage animal testing, instead favoring alternative research models.

October 17, 2025

Vol.51 No.38

By Claire Marie Porter and Jacquelyn Cobb

Cancer Policy

Federal judge puts temporary block on new round of CDC and HHS layoffs

A federal judge issued a temporary restraining order on Oct. 15, ordering the Trump administration to reverse the wave of layoffs that the administration is using as a pressure tactic intended to force the Democrats to accept cuts to popular health programs and reopen the government.

NIH announces restrictions on human biospecimen sharing with China and other foreign adversaries

NIH has published a policy that prohibits U.S. researchers and NIH grant recipients working with human biospecimens to share this data with “countries of concern.” That list includes China (including Hong Kong and Macau), Russia, Iran, North Korea, Cuba, and Venezuela.

October 10, 2025

Vol.51 No.37

By Sara Willa Ernst

NIDA director Volkow gets candid on addiction in Bhattacharya’s podcast

YOU MAY BE INTERESTED IN

Science advocates organize march in DC to demand impeachment of RFK Jr.

Federal official claims that temporary order blocking RIFs doesn’t apply to HHS

Under the lens: Taking a close look at the NIH and FDA declarations on animal-based research

How animal testing became a MAHA political wedge issue
While cancer scientists say NIH, FDA moves are premature, animal rights advocates say changes aren’t drastic enough

Federal judge puts temporary block on new round of CDC and HHS layoffs

NIH announces restrictions on human biospecimen sharing with China and other foreign adversaries

Renew today!

Subscriber content

Never miss an issue!

Login

NIDA director Volkow gets candid on addiction in Bhattacharya’s podcast

YOU MAY BE INTERESTED IN

Science advocates organize march in DC to demand impeachment of RFK Jr.

Federal official claims that temporary order blocking RIFs doesn’t apply to HHS

Under the lens: Taking a close look at the NIH and FDA declarations on animal-based research

How animal testing became a MAHA political wedge issueWhile cancer scientists say NIH, FDA moves are premature, animal rights advocates say changes aren’t drastic enough

Federal judge puts temporary block on new round of CDC and HHS layoffs

NIH announces restrictions on human biospecimen sharing with China and other foreign adversaries

Never miss an issue!

Login

How animal testing became a MAHA political wedge issue
While cancer scientists say NIH, FDA moves are premature, animal rights advocates say changes aren’t drastic enough